Kiwi Instruments(688045)

Search documents
必易微(688045) - 董事会薪酬与考核委员会关于公司2025年限制性股票激励计划相关事项的核查意见
2025-08-15 12:30
(4)法律法规规定不得实行股权激励的; (5)中国证监会认定的其他情形。 综上,公司具备实施股权激励计划的主体资格。 深圳市必易微电子股份有限公司董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划相关事项的核查意见 深圳市必易微电子股份有限公司(以下简称"公司")董事会薪酬与考核委 员会(以下简称"薪酬委员会")依据《中华人民共和国公司法》(以下简称"《公 司法》")、《中华人民共和国证券法》(以下简称"《证券法》")、《上市 公司股权激励管理办法》(以下简称"《管理办法》")、《上海证券交易所科 创板股票上市规则》(以下简称"《上市规则》")、《科创板上市公司自律监 管指南第 4 号——股权激励信息披露》(以下简称"《自律监管指南》")、《必 易微电子股份有限公司公司章程》(以下简称"《公司章程》")等有关规定, 对公司 2025 年限制性股票激励计划(以下简称"本次激励计划")相关事项进 行核查,发表核查意见如下: 1、公司不存在《管理办法》等法律、法规规定的禁止实施股权激励计划的 情形,包括: (1)最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法 表示意见的审计报告; (2) ...
必易微(688045) - 必易微第二届董事会第十七次会议决议公告
2025-08-15 12:30
二、董事会会议审议情况 本次会议以书面表决方式进行表决,经与会董事审议,通过了如下议案: (一)关于公司《2025 年半年度报告》及其摘要的议案 经审查,董事会认为公司《2025 年半年度报告》及其摘要的编制和审议程 序符合相关法律法规及《公司章程》等内部规章制度的规定;公司《2025 年半 年度报告》及其摘要的内容与格式符合相关规定,并公允地反映了公司 2025 年 半年度的财务状况和经营成果等事项。 证券代码:688045 证券简称:必易微 公告编号:2025-028 深圳市必易微电子股份有限公司 第二届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 深圳市必易微电子股份有限公司(以下简称"公司")第二届董事会第十七 次会议(以下简称"本次会议"或"会议")于 2025 年 8 月 15 日以现场结合通 讯会议方式在公司会议室召开。本次会议已于 2025 年 8 月 8 日以邮件方式发出 会议通知,由董事长谢朋村先生召集和主持,应出席董事 7 人,实际出席董事 7 人 ...
必易微(688045) - 2025 Q2 - 季度财报
2025-08-15 12:25
[Glossary](index=4&type=section&id=Glossary) This section provides definitions for key terms used within the report [Company Profile and Key Financial Indicators](index=6&type=section&id=Company%20Profile%20and%20Key%20Financial%20Indicators) Overview of the company's basic information and a summary of its key financial performance and position [Company Basic Information](index=6&type=section&id=Company%20Basic%20Information) Biyi Micro is a Shenzhen-registered joint-stock company specializing in the design and sale of high-performance analog and mixed-signal integrated circuits, with Xie Pengcun as its legal representative - The company's full Chinese name is "Shenzhen Biyi Microelectronics Co., Ltd.", abbreviated as "Biyi Micro", with Xie Pengcun as its legal representative[14](index=14&type=chunk) [Key Accounting Data and Financial Indicators](index=7&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) During the reporting period, the company's operating revenue decreased by 6.99% year-over-year, while net loss attributable to shareholders narrowed; net cash flow from operating activities decreased by 43.56% due to reduced government subsidies and increased payroll taxes, yet cost control and product adjustments led to a 12.76 million CNY reduction in non-recurring loss and improved gross margin Key Accounting Data (January-June 2025) | Key Accounting Data | Current Period (Jan-Jun) | Prior Year Period | Year-over-year Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 282.58 million CNY | 303.82 million CNY | -6.99% | | Net Profit Attributable to Shareholders of Listed Company | -8.81 million CNY | -10.61 million CNY | N/A | | Net Profit Attributable to Shareholders of Listed Company After Deducting Non-Recurring Gains and Losses | -14.52 million CNY | -27.28 million CNY | N/A | | Net Cash Flow from Operating Activities | 4.15 million CNY | 7.36 million CNY | -43.56% | | **Asset Status** | **End of Current Period** | **End of Prior Year** | **Year-over-year Change (%)** | | Net Assets Attributable to Shareholders of Listed Company | 1.37 billion CNY | 1.36 billion CNY | 1.34% | | Total Assets | 1.44 billion CNY | 1.46 billion CNY | -1.37% | Key Financial Indicators (January-June 2025) | Key Financial Indicators | Current Period (Jan-Jun) | Prior Year Period | Year-over-year Change (%) | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (CNY/share) | -0.13 | -0.15 | N/A | | Weighted Average Return on Net Assets (%) | -0.62 | -0.76 | increased by 0.14 percentage points | | Weighted Average Return on Net Assets After Deducting Non-Recurring Gains and Losses (%) | -1.03 | -1.96 | increased by 0.93 percentage points | | R&D Expenditure as % of Operating Revenue (%) | 25.42 | 27.91 | decreased by 2.49 percentage points | - Net loss attributable to shareholders after deducting non-recurring gains and losses narrowed by **12.76 million CNY** year-over-year, primarily due to the company's cost reduction efforts through design refinement, process upgrades, and supply chain optimization, coupled with proactive adjustments to product structure and market pricing strategies, leading to an increase in product gross margin[22](index=22&type=chunk) - During the reporting period, total non-recurring gains and losses amounted to **5.71 million CNY**, primarily from fair value changes and disposal gains/losses on financial assets and liabilities held by non-financial enterprises[26](index=26&type=chunk) [Management Discussion and Analysis](index=10&type=section&id=Management%20Discussion%20and%20Analysis) Management's review and analysis of the company's operations, financial condition, and future outlook [Industry and Main Business Overview](index=10&type=section&id=Industry%20and%20Main%20Business%20Overview) The company specializes in high-performance analog and mixed-signal IC design and sales, with products spanning power management, motor drive control, battery management, signal chain, and microcontrollers; the industry benefits from AI, new energy, and 5G, driving steady market demand and significant domestic substitution opportunities across various applications [Industry Overview](index=10&type=section&id=Industry%20Overview) The company operates in the integrated circuit design industry, benefiting from AI, new energy, 5G, and IoT, driving steady global and Chinese market growth; global semiconductor sales are projected to reach 697 billion USD by 2025, with China's IC market at 1.89 trillion CNY, while the analog chip market in China is expected to reach 333.95 billion CNY by 2025 with significant domestic substitution potential, and the global MCU market is forecast to reach 38.8 billion USD by 2028 Integrated Circuit Industry Market Size Forecast | Market | Forecast Year | Forecast Size | | :--- | :--- | :--- | | Global Semiconductor Sales | 2025 | 697.0 billion USD | | China Integrated Circuit | 2025 | 1.89 trillion CNY | | China Analog Chip | 2025 | 333.95 billion CNY | | Global MCU | 2028 | 38.8 billion USD | - The company operates in the integrated circuit design industry with broad downstream applications; benefiting from global semiconductor supply chain shifts and domestic policy support, China's integrated circuit industry is rapidly growing, with its market size projected to reach **1.89 trillion CNY** by 2025[29](index=29&type=chunk) - China is the world's largest analog chip consumption market with a growth rate exceeding the global average; despite immense market demand, domestic self-sufficiency is low, indicating vast import substitution potential, with China's analog chip market size projected to grow to **333.95 billion CNY** by 2025[30](index=30&type=chunk) [Main Business and Key Products](index=11&type=section&id=Main%20Business%20and%20Key%20Products) The company's main business is the design and sale of high-performance analog and mixed-signal integrated circuits, offering a comprehensive product matrix primarily categorized into five types: power management, motor drive control, battery management, signal chain, and microcontrollers - The company offers a comprehensive product portfolio covering five major categories: power management, motor drive control, battery management, signal chain, and microcontrollers, providing customers with one-stop chip solutions[32](index=32&type=chunk) [Discussion and Analysis of Operations](index=14&type=section&id=Discussion%20and%20Analysis%20of%20Operations) In H1 2025, overall revenue declined nearly 7% year-over-year, mainly due to weak LED driver chip demand, yet new products like motor drive control and DC-DC saw 64.57% growth, driving a nearly 30% sequential revenue increase in Q2; cost reduction and efficiency gains led to four consecutive quarters of gross margin improvement, reaching nearly 30% in Q2, with net loss narrowing by 16.92% in H1 and Q2 achieving a net profit of 4.32 million CNY H1 2025 Operational Highlights | Indicator | Performance | Source | | :--- | :--- | :--- | | **Overall Revenue** | Declined nearly 7% year-over-year | Primarily affected by LED driver chip business | | **New Product Revenue** | Motor drive control, DC-DC, etc., grew 64.57% year-over-year | Successful product structure adjustment | | **Quarterly Growth** | Q2 revenue grew nearly 30% sequentially | New product volume ramp-up | | **Gross Margin** | Grew for four consecutive quarters, Q2 nearly 30% | Cost reduction, efficiency gains, pricing strategy adjustment | | **Net Profit** | H1 net profit attributable to parent company -8.81 million CNY, loss narrowed by 16.92% year-over-year | Improved profitability | | **Q2 Net Profit** | Achieved net profit attributable to parent company of 4.32 million CNY, sequential growth of 132.88% | Quarterly turnaround to profit | - R&D investment remained high, with expenses reaching **71.85 million CNY** in H1 2025, accounting for **25.42%** of operating revenue[43](index=43&type=chunk)[44](index=44&type=chunk) - The company achieved significant progress across multiple product lines, including AC-DC, LED drivers, motor drive control, DC-DC, battery management, digital isolation, and MCUs, continuously launching new products and successfully integrating them into the supply chains of several leading customers[46](index=46&type=chunk)[47](index=47&type=chunk)[48](index=48&type=chunk)[49](index=49&type=chunk)[50](index=50&type=chunk)[51](index=51&type=chunk) [Analysis of Core Competencies](index=16&type=section&id=Analysis%20of%20Core%20Competencies) The company's core competencies include continuous R&D innovation, a mature and stable R&D and management team, reliable supply channels, and a 'head effect' market promotion model; during the period, six new core technologies were added, accumulating 242 patents, with H1 R&D investment at 71.85 million CNY, accounting for 25.42% of revenue, and R&D personnel comprising nearly 70% of the workforce - The company's core competencies include: - **Continuous R&D innovation**: Mastering core technologies such as high-voltage integrated processes and low-power consumption control - **Talent and management team**: Experienced core R&D team, with R&D personnel accounting for over **69%** - **Reliable supply channels**: Adopting a Fabless model with close supplier collaboration - **Market promotion model**: Focusing on serving key accounts, creating a 'head effect' that facilitates rapid product market entry[52](index=52&type=chunk)[53](index=53&type=chunk)[54](index=54&type=chunk) [Core Technologies and R&D Progress](index=17&type=section&id=Core%20Technologies%20and%20R%26D%20Progress) During the reporting period, the company added six core technologies, including rapid input overvoltage protection and high-precision LLC primary-side constant current control; as of period-end, it held 242 domestic and international patents (129 invention patents) and 583 integrated circuit layout designs; H1 R&D investment was 71.85 million CNY, representing 25.42% of revenue, with ongoing development in five major projects including AC-DC, motor drive, DC-DC, battery management, and signal chain chips - Six new core technologies were added during the reporting period, including: rapid response input overvoltage protection technology, high-precision LLC primary-side constant current control solution, adaptive dynamic response threshold technology, high-efficiency three-phase BLDC motor drive freewheeling control technology, high-reliability half-bridge IPM dedicated gate drive technology, and high-reliability optocoupler-compatible isolated gate drive technology[60](index=60&type=chunk) R&D Investment Overview | Item | Current Period Amount (CNY) | Prior Year Period Amount (CNY) | Change (%) | | :--- | :--- | :--- | :--- | | Expensed R&D Investment | 71.85 million CNY | 84.78 million CNY | -15.26% | | Total R&D Investment as % of Revenue (%) | 25.42% | 27.91% | decreased by 2.49 percentage points | R&D Personnel Overview | Item | Current Period Amount (persons) | Prior Year Period Amount (persons) | | :--- | :--- | :--- | | Number of R&D Personnel (persons) | 261 | 254 | | R&D Personnel as % of Total Company Headcount (%) | 69.79% | 70.17% | [Risk Factors](index=25&type=section&id=Risk%20Factors) The company faces multi-faceted risks, including potential significant performance decline or loss if industry demand recovery or new product ramp-up falls short of expectations, core technology leakage and talent loss, intense market competition, reliance on external manufacturers for quality control, accounts receivable impairment and inventory write-down risks, and broader macroeconomic fluctuations and international trade frictions - The company faces key risks including: - **Performance risk**: Potential losses due to sustained high R&D investment if market demand or new product ramp-up falls short of expectations[72](index=72&type=chunk) - **Core competency risk**: Technology leakage, talent attrition, and inability of product iteration to keep pace with market demand[73](index=73&type=chunk)[74](index=74&type=chunk)[75](index=75&type=chunk) - **Operational risk**: Intensified market competition and reliance on external suppliers for product quality control[76](index=76&type=chunk)[77](index=77&type=chunk) - **Financial risk**: Accounts receivable impairment and inventory write-down risks[77](index=77&type=chunk)[78](index=78&type=chunk) - **Industry and macroeconomic risk**: Downstream market demand fluctuations and international trade frictions[79](index=79&type=chunk) [Analysis of Assets and Liabilities](index=28&type=section&id=Analysis%20of%20Assets%20and%20Liabilities) As of the reporting period end, total assets were 1.44 billion CNY, a slight 1.37% decrease from year-end; significant asset structure changes include a 69.57% decrease in monetary funds, primarily due to investments in wealth management products, real estate, and equity, leading to substantial increases in financial assets held for trading, construction in progress, and other non-current financial assets, while employee compensation payable decreased by 67.12% due to prior year bonus payments Major Balance Sheet Item Changes | Item Name | Amount at Period End (CNY) | Change from Prior Year End (%) | Primary Reason | | :--- | :--- | :--- | :--- | | Monetary Funds | 293.31 million CNY | -69.57% | Purchase of wealth management products, real estate, and increased equity investments | | Financial Assets Held for Trading | 614.36 million CNY | N/A | Purchase of wealth management products | | Construction in Progress | 26.49 million CNY | N/A | Newly acquired real estate not yet ready for use | | Other Non-Current Financial Assets | 58.00 million CNY | 222.22% | New equity investments | | Employee Compensation Payable | 8.58 million CNY | -67.12% | Payment of prior year bonuses | [Corporate Governance, Environment, and Society](index=33&type=section&id=Corporate%20Governance%2C%20Environment%2C%20and%20Society) Details on corporate governance structure, changes in key personnel, and social responsibility initiatives [Changes in Directors, Supervisors, Senior Management, and Core Technical Personnel](index=33&type=section&id=Changes%20in%20Directors%2C%20Supervisors%2C%20Senior%20Management%2C%20and%20Core%20Technical%20Personnel) During the reporting period, based on the company's long-term strategic development plan and R&D project progress, Mr. Wang Yi was no longer designated as a core technical personnel - During the reporting period, Mr. Wang Yi was no longer designated as a core technical personnel due to adjustments in the company's strategic development plan[96](index=96&type=chunk) [Equity Incentive and Employee Stock Ownership Plans](index=33&type=section&id=Equity%20Incentive%20and%20Employee%20Stock%20Ownership%20Plans) During the reporting period, the company cancelled certain restricted shares from the 2022, 2023, and 2024 incentive plans due to reasons like employee departures or unmet performance targets, completed the first vesting period of the 2024 restricted stock incentive plan, terminated the second phase of the 2024 restricted stock incentive plan, and the lock-up period for the 2024 employee stock ownership plan expired on May 7, 2025 - The company cancelled certain restricted shares due to incentive recipients' departures or the company's/individual's failure to meet performance targets[97](index=97&type=chunk) - The first vesting period of the 2024 restricted stock incentive plan completed share registration, with **788,880 shares** vested, increasing the company's total share capital[98](index=98&type=chunk) - The company terminated the implementation of the second phase of the 2024 restricted stock incentive plan[98](index=98&type=chunk) [Significant Events](index=36&type=section&id=Significant%20Events) Information on significant commitments, use of raised funds, and other material events affecting the company [Fulfillment of Commitments](index=36&type=section&id=Fulfillment%20of%20Commitments) During the reporting period, the company's actual controller, shareholders, related parties, and the company itself strictly fulfilled all commitments made during the initial public offering, including share lock-up, price stabilization, information disclosure accuracy, avoidance of horizontal competition, and regulation of related party transactions; certain shareholders' share lock-up periods were automatically extended by six months due to triggered conditions - The company's controlling shareholder, actual controller Xie Pengcun, and his concerted parties, along with certain directors, supervisors, and senior management, committed not to transfer pre-IPO shares within **36 months** from the company's listing date[103](index=103&type=chunk)[105](index=105&type=chunk) - Due to triggering the condition of "closing price falling below the offering price for 20 consecutive trading days within 6 months after listing," the lock-up period for pre-IPO shares held by relevant committing parties was automatically extended by **6 months**, until November 25, 2025[149](index=149&type=chunk) [Explanation of Progress in Use of Raised Funds](index=87&type=section&id=Explanation%20of%20Progress%20in%20Use%20of%20Raised%20Funds) As of the reporting period end, the company's net proceeds from its initial public offering totaled 861 million CNY, with cumulative investment reaching 610 million CNY, representing a 70.88% progress rate, primarily allocated to power management and motor drive control chip development and industrialization projects, and R&D center construction; during the period, internal investment structures for some projects were adjusted, and the expected completion dates for two major industrialization projects were extended to May 2027 Overall Use of Raised Funds | Item | Amount (CNY) | | :--- | :--- | | Net Proceeds from Raised Funds | 860.78 million CNY | | Total Committed Investment | 652.52 million CNY | | Cumulative Investment as of Period End | 610.11 million CNY | | Overall Investment Progress | 70.88% | - The company adjusted the internal investment structure for the "Power Management Series Control Chip Development and Industrialization Project" and the "Motor Drive Control Chip Development and Industrialization Project," extending their expected completion dates to **May 2027**[170](index=170&type=chunk) [Share Changes and Shareholder Information](index=93&type=section&id=Share%20Changes%20and%20Shareholder%20Information) Analysis of changes in share capital and detailed information regarding the company's shareholders [Changes in Share Capital](index=93&type=section&id=Changes%20in%20Share%20Capital) During the reporting period, the company issued 788,880 shares to incentive recipients due to the first vesting period of the 2024 restricted stock incentive plan, increasing total share capital from 69,048,939 shares to 69,837,819 shares - Due to the completion of the first vesting period of the 2024 restricted stock incentive plan, the company's total share capital increased from **69,048,939 shares** to **69,837,819 shares**, with **788,880 new shares** issued[175](index=175&type=chunk)[176](index=176&type=chunk) [Shareholder Information](index=94&type=section&id=Shareholder%20Information) As of the reporting period end, the company had 6,014 common shareholders; among the top ten shareholders, controlling shareholder and actual controller Xie Pengcun held 18.39%, with Suzhou Fangguang Phase II Venture Capital Partnership (Limited Partnership) as the second largest at 10.23%, indicating a relatively concentrated equity structure among the top ten Top Ten Shareholders' Holdings | Shareholder Name | Shares Held at Period End (shares) | Percentage (%) | | :--- | :--- | :--- | | Xie Pengcun | 12,844,050 | 18.39% | | Suzhou Fangguang Phase II Venture Capital Partnership (Limited Partnership) | 7,143,000 | 10.23% | | Shenzhen Kaiweis Enterprise Management Center (Limited Partnership) | 5,001,950 | 7.16% | | Yuan Chengjun | 4,671,051 | 6.69% | | Shenzhen Kawester Enterprise Management Center (Limited Partnership) | 4,633,900 | 6.64% | | Zhang Bo | 4,285,700 | 6.14% | | Shenzhen Kawete Enterprise Management Center (Limited Partnership) | 3,312,300 | 4.74% | | Yu Huijie | 2,142,850 | 3.07% | | Beijing Fenghui Investment Management Co., Ltd. | 1,900,000 | 2.72% | | Shenzhen Meikai Shanhe Enterprise Management Consulting Partnership (Limited Partnership) | 433,789 | 0.62% | - Controlling shareholder Xie Pengcun is a concerted party with shareholders Zhang Bo and Yu Huijie; Xie Pengcun also serves as the executive partner for employee stock ownership platforms Kawete, Kawester, and Kaiweis[181](index=181&type=chunk) [Bond-Related Information](index=100&type=section&id=Bond-Related%20Information) Overview of the company's outstanding bonds and other debt financing instruments [Company Bonds and Other Debt Financing Instruments](index=100&type=section&id=Company%20Bonds%20and%20Other%20Debt%20Financing%20Instruments) During the reporting period, the company had no outstanding corporate bonds, enterprise bonds, or non-financial enterprise debt financing instruments - The company had no corporate bonds or non-financial enterprise debt financing instruments during the current reporting period[191](index=191&type=chunk) [Financial Report](index=101&type=section&id=Financial%20Report) Presents the company's unaudited consolidated and parent company financial statements for the period [Consolidated Balance Sheet](index=101&type=section&id=Consolidated%20Balance%20Sheet) As of June 30, 2025, the company's total assets were 1.44 billion CNY, total liabilities 107 million CNY, and equity attributable to parent company owners 1.37 billion CNY, with a debt-to-asset ratio of 7.43%; compared to the beginning of the period, asset structure significantly changed, with decreased monetary funds and increased financial assets held for trading and construction in progress Consolidated Balance Sheet Summary | Item | June 30, 2025 (CNY) | December 31, 2024 (CNY) | | :--- | :--- | :--- | | **Total Current Assets** | 1.21 billion CNY | 1.30 billion CNY | | **Total Non-Current Assets** | 228.77 million CNY | 160.08 million CNY | | **Total Assets** | **1.44 billion CNY** | **1.46 billion CNY** | | **Total Current Liabilities** | 98.30 million CNY | 131.44 million CNY | | **Total Non-Current Liabilities** | 8.66 million CNY | 10.40 million CNY | | **Total Liabilities** | **106.97 million CNY** | **141.84 million CNY** | | **Total Equity Attributable to Parent Company Owners** | 1.37 billion CNY | 1.36 billion CNY | | **Total Owners' Equity** | **1.33 billion CNY** | **1.32 billion CNY** | [Consolidated Income Statement](index=107&type=section&id=Consolidated%20Income%20Statement) In H1 2025, the company achieved operating revenue of 283 million CNY, a 6.99% year-over-year decrease; operating cost decreased by 12.65% to 199 million CNY, improving gross margin from 25.0% to 29.6%; R&D expenses were 71.85 million CNY, accounting for 25.4% of revenue, resulting in a net loss attributable to parent company shareholders of 8.82 million CNY, a narrower loss compared to 10.61 million CNY in the prior year Consolidated Income Statement Summary | Item | H1 2025 (CNY) | H1 2024 (CNY) | | :--- | :--- | :--- | | **Operating Revenue** | **282.58 million CNY** | **303.82 million CNY** | | Operating Cost | 199.00 million CNY | 227.82 million CNY | | **Gross Profit** | **83.58 million CNY** | **76.00 million CNY** | | R&D Expenses | 71.85 million CNY | 84.78 million CNY | | **Operating Profit** | **-14.77 million CNY** | **-20.13 million CNY** | | Total Profit | -14.86 million CNY | -20.14 million CNY | | **Net Profit** | **-12.06 million CNY** | **-19.47 million CNY** | | **Net Profit Attributable to Parent Company Shareholders** | **-8.81 million CNY** | **-10.61 million CNY** | [Consolidated Cash Flow Statement](index=111&type=section&id=Consolidated%20Cash%20Flow%20Statement) In H1 2025, net cash flow from operating activities was 4.15 million CNY, a 43.6% year-over-year decrease; net cash outflow from investing activities was 583 million CNY, primarily for wealth management products and long-term asset acquisition; net cash inflow from financing activities was 8.07 million CNY, mainly from capital contributions, resulting in a significant decrease in cash and cash equivalents to 293 million CNY at period-end Consolidated Cash Flow Statement Summary | Item | H1 2025 (CNY) | H1 2024 (CNY) | | :--- | :--- | :--- | | **Net Cash Flow from Operating Activities** | **4.15 million CNY** | **7.36 million CNY** | | **Net Cash Flow from Investing Activities** | **-582.62 million CNY** | **-445.28 million CNY** | | **Net Cash Flow from Financing Activities** | **8.07 million CNY** | **-22.32 million CNY** | | Effect of Exchange Rate Changes on Cash | -845.47 CNY | 1,105.66 CNY | | **Net Increase in Cash and Cash Equivalents** | **-570.40 million CNY** | **-460.24 million CNY** | | Cash and Cash Equivalents at Beginning of Period | 863.71 million CNY | 724.17 million CNY | | **Cash and Cash Equivalents at End of Period** | **293.31 million CNY** | **263.94 million CNY** |
多家上市公司董事长提议回购股份 或将用于股权激励
Xin Hua Wang· 2025-08-12 05:48
又有多家上市公司股东提议进行回购,或为市场上行积蓄更多力量。 8月20日晚间,亿帆医药(002019)公告称,收到公司控股股东、实际控制人、董事长兼总裁程先锋提交 的回购公司股份的函。 基于对亿帆医药未来发展的信心和对公司长期价值的认可,为增强投资者对公司的信心,维护广大投资 者的利益,结合公司经营情况、业务发展前景、公司财务状况及未来的盈利能力,程先锋提议公司使用 自有资金以集中竞价交易方式回购公司股份,并在未来适宜时机将回购股份用于员工持股计划或股权激 励。若公司未能在股份回购实施结果暨股份变动公告日后3年内转让已回购股份,将依法履行减少注册 资本的程序,注销未转让股份。 程先锋本次提议回购股份的价格不超过20.57元/股(含),回购资金总额3000万元(含)~5000万元 (含)。 此外,也有上市公司股东计划增持股份。 东箭科技(300978)8月20日晚间公告,基于对公司未来发展的坚定信心和长期投资价值的认可,公司控 股股东、实际控制人、董事长马永涛计划自公告披露之日起6个月内增持公司股份,拟增持金额1000万 元~2000万元,本次增持计划不设置增持股份价格区间。 棒杰股份(002634)8月20日 ...
华安证券:TI芯片涨价在即 模拟芯片国产替代有望加速
智通财经网· 2025-08-11 11:39
智通财经APP获悉,华安证券发布研报称,德州仪器将在8月启动新一波涨价,幅度超过6月,若特定料 号TI涨价幅度较大,且国产模拟芯片厂商愿意维持价格(不跟进TI涨价)或进一步降价,则在一段时间验 证后的新品量产中也可进行国产替代,TI目前涨价将使得公司保障其现有财务表现但牺牲产品份额。该 行认为国产模拟芯片厂商将有更多机会实现在工业和汽车应用领域,以及高端消费领域的国产替代。 模拟芯片领域相关公司包括:思瑞浦(688536.SH)、杰华特(688141.SH)、圣邦股份(300661.SZ)、纳芯微 (688052.SH)、艾为电子(688798.SH)、希荻微(688173.SH)、必易微(688045.SH)、南芯科技(688484.SH) 等。 华安证券主要观点如下: 德州仪器料号涨价,幅度或将超过6月 根据国际电子商情综合报道,TI将在8月启动新一波涨价,幅度超过6月,重点涉及工控类、车载类、以 及算力相关芯片产品,覆盖LDO(低压差线性稳压器)、DC-DC(直流-直流转换器)、数字隔离、隔离驱动 等品类。而且调价范围不仅涉及终端客户,还覆盖了除超级大客户外的几乎所有客户群体,且价格上调 将通过代理商传 ...
必易微(688045)8月8日主力资金净流出1456.69万元
Sou Hu Cai Jing· 2025-08-08 11:03
金融界消息 截至2025年8月8日收盘,必易微(688045)报收于38.0元,下跌4.28%,换手率6.45%,成 交量2.43万手,成交金额9302.87万元。 天眼查商业履历信息显示,深圳市必易微电子股份有限公司,成立于2014年,位于深圳市,是一家以从 事软件和信息技术服务业为主的企业。企业注册资本6983.7819万人民币,实缴资本5038.7万人民币。公 司法定代表人为谢朋村。 通过天眼查大数据分析,深圳市必易微电子股份有限公司共对外投资了9家企业,参与招投标项目6次, 知识产权方面有商标信息15条,专利信息214条,此外企业还拥有行政许可20个。 来源:金融界 资金流向方面,今日主力资金净流出1456.69万元,占比成交额15.66%。其中,超大单净流入88.16万 元、占成交额0.95%,大单净流出1544.85万元、占成交额16.61%,中单净流出流入607.98万元、占成交 额6.54%,小单净流入848.71万元、占成交额9.12%。 必易微最新一期业绩显示,截至2025一季报,公司营业总收入1.23亿元、同比减少9.28%,归属净利润 1313.25万元,同比减少4708.31%,扣非 ...
必易微: 必易微股份质押公告
Zheng Quan Zhi Xing· 2025-07-21 16:34
Group 1 - The core point of the announcement is that Yu Huijie, a concerted actor of the controlling shareholder and actual controller Xie Pengcun, has pledged 400,000 shares of Shenzhen Biyimi Microelectronics Co., Ltd., accounting for 0.57% of the company's total share capital [1][2] - Yu Huijie holds a total of 2,142,850 shares, which represents 3.07% of the company's total share capital, and the pledged shares account for 18.67% of his total holdings [1][2] - The pledge is for personal funding needs and does not lead to any change in the actual control of the company, nor does it have a substantial impact on the company's operations or governance [2]
必易微(688045) - 必易微股份质押公告
2025-07-21 11:15
一、本次股份质押情况 二、其他说明 证券代码:688045 证券简称:必易微 公告编号:2025-027 深圳市必易微电子股份有限公司股份质押公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 深圳市必易微电子股份有限公司(以下简称"公司")控股股东、实际控 制人谢朋村之一致行动人喻辉洁持有公司股份 2,142,850 股,占公司总股本的比 例为 3.07%。喻辉洁先生本次质押公司股份 400,000 股,占其所持公司股份的比 例为 18.67%,占公司总股本的比例为 0.57%。 公司于近日收到控股股东、实际控制人谢朋村之一致行动人喻辉洁通知,获 悉其持有的部分公司股份被质押,现将具体情况公告如下: | 出质人 | 喻辉洁 | | | | | --- | --- | --- | --- | --- | | 股东身份 | 控股股东之一致行动人 | | | | | 本次质押数量(股) | 400,000 | | | | | 占公司总股本的比例 | 0.57% | | | | | 是否为限售股 | 是 | | ...
7月8日早间重要公告一览
Xi Niu Cai Jing· 2025-07-08 10:11
Group 1 - Sannuo Group expects a net loss of 100 million to 120 million yuan for the first half of 2025, a significant decline from a profit of 7.4 million yuan in the same period last year [1] - The company anticipates a net loss of 77 million to 95 million yuan after excluding non-recurring gains and losses [1] - Basic earnings per share are projected to be a loss of 0.2148 to 0.2578 yuan per share [1] Group 2 - Landai Technology is planning to transfer 18% of its shares, which may lead to a change in control [2] - The stock of Landai Technology has been suspended from trading since July 8, 2025, with an expected suspension period of no more than two trading days [2] Group 3 - Xinxin Co. announced that a senior executive plans to reduce their holdings by up to 750,000 shares, representing no more than 0.2971% of the total share capital [3] - The reason for the reduction is personal financial needs [3] Group 4 - Biyimi plans to reduce its shares by a total of up to 3% by two shareholders, with one shareholder planning to reduce up to 139.68 million shares (2.00%) and the other up to 69.84 million shares (1.00%) [4] - The reason for the reduction is also personal financial needs [4] Group 5 - Changxin Bochuang announced that shareholders plan to reduce their holdings by up to 2.95%, totaling 8.6 million shares [6] - The reason for the reduction is personal financial needs [6] Group 6 - Tianci Materials plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 7 - Sanxiang Impression announced the termination of a previous equity transfer agreement, following a request from its controlling shareholder [10] Group 8 - Zhongke Technology has decided to terminate its plan to issue shares for asset acquisition and related fundraising due to changes in market conditions [12] Group 9 - Hangcha Group's subsidiary plans to acquire 99.23% of Guozu Robot's shares through capital increase [14] Group 10 - Xishan Technology plans to increase its holdings in the company by no less than 5 million and no more than 10 million yuan [19] Group 11 - New Hope reported sales of 1.33 million pigs in June, a year-on-year increase of 3.38% [21] - The sales revenue was 1.871 billion yuan, a year-on-year decrease of 19.14% [21] Group 12 - Auhua Endoscope announced that two shareholders plan to reduce their holdings by up to 1.92% [18] Group 13 - Star Source Material has submitted an application for H-share issuance and listing [18] Group 14 - Yilian Technology plans to invest 20 million yuan to establish a partnership with professional institutions [30]
破发股必易微两大股东拟减持 IPO超募2亿申万宏源保荐
Zhong Guo Jing Ji Wang· 2025-07-08 07:46
Group 1 - The major shareholders of Biyimi (688045.SH) plan to reduce their holdings due to personal funding needs, with a total reduction of up to 1,396,756 shares, representing 2.00% of the total share capital [1] - The shareholder Suzhou Fangguang Phase II Venture Capital Partnership intends to reduce its holdings from July 29, 2025, to October 28, 2025, through both centralized bidding and block trading [1] - The shareholder Yuan Chengjun also plans to reduce his holdings by up to 698,378 shares, representing 1.00% of the total share capital, during the same period [1] Group 2 - As of the announcement date, Fangguang Phase II holds 7,143,000 shares, accounting for 10.23% of Biyimi's total share capital, while Yuan Chengjun holds 4,671,051 shares, accounting for 6.69% [2] - Both shareholders acquired their shares before Biyimi's initial public offering (IPO), which took place on May 26, 2023 [2] - Biyimi's IPO raised a total of 95,201.58 million yuan, with a net amount of 86,077.79 million yuan after deducting issuance costs, exceeding the original plan by 20,826.29 million yuan [2] Group 3 - The total issuance costs for Biyimi's IPO amounted to 9,123.79 million yuan, including underwriting fees of 7,185.03 million yuan and sponsorship fees of 94.34 million yuan [3]